ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Hui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7287-2690; OpenAlex author ID A5027041268. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. Last author DOI 10.1080/15384047.2018.1564565 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weidong Ma · 1 shared paper, 2019 · strength 0.11
- Paper LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. DOI 10.1080/15384047.2018.1564565 ↗
Ting Li · 1 shared paper, 2019 · strength 0.11
- Paper LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. DOI 10.1080/15384047.2018.1564565 ↗
Xiuchao Wang · 1 shared paper, 2019 · strength 0.11
- Paper LOX and ACSL5 as potential relapse markers for pancreatic cancer patients. DOI 10.1080/15384047.2018.1564565 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.